United States· US:0187-5812_45372e42-065d-4d87-89af-d5dcf09c29fb
Aplenzin
A medicinal product containing bupropion hydrobromide, registered in United States by Bausch Health US, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- BUPROPION HYDROBROMIDE
- Manufacturer
- Bausch Health US, LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1101875812077 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5812-07)
- ndc11018758123030 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5812-30)
- ndc110187-5812-30
- ndc110187-5812-07
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bupropion hydrobromide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandBucidarRanbaxy (Poland) Sp. z o.o.
- CzechiaBUPROPION +PHARMA+pharma arzneimittel gmbh, Graz
- SwedenBupropion Accord 150 mg Tablett med modifierad frisättningAccord Healthcare B.V.
- NetherlandsBupropion HCL 150 mg Focus Care, tabletten met gereguleerde afgifteFocus Care Pharmaceuticals B.V.
- SpainBUPROPION ACCORD 150 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFGAccord Healthcare S.L.U.
- FinlandBupropion AccordAccord Healthcare B.V.
- GermanyBupropionBetapharm Arzneimittel Gmbh
- BelgiumBupropion EG 300 mgEG
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Bupropion !$tada, Bupropion +pharma
- Belgium · Bupropion Eg, Bupropion Sandoz
- Cyprus · Wellbutrin Xr
- Czechia · Bupropion +pharma, Bupropion Neuraxpharm
- Germany · Bupropion, Bupropion 1 A Pharma
- Denmark · Bupropion Hydrochloride Zentiva, Bupropionhydrochlorid Stada
- Estonia · Elontril
- Spain · Bupropion Accord, Bupropión Cinfa
- Finland · Bupropion Accord, Bupropion Omet Pharma
- France · Zyban L.P.
- United Kingdom (Northern Ireland) · Zyban
- Greece · Wellbutrin Xr
- Croatia · Bupropion Genericon, Wellbutrin Xr
- Hungary · Elontril
- Ireland · Zyban
- Iceland · Bupropion Teva, Wellbutrin Retard
- Italy · Bupropion Sun, Bupropione Doc
- Lithuania · Elontril
- Luxembourg · Bupropion Eg, Bupropion Ratiopharm
- Latvia · Wellbutrin Sr
- Malta · Bupropion Generis, Wellbutrin Xr
- Netherlands · Bupropion Hcl 1a Retard 1a Pharma, Bupropion Hcl Accord
- Norway · Bupropion Hydrochloride Teva, Bupropion Hydrochloride Zentiva
- Poland · Bucidar, Bupropion
- Portugal · Bupropiom Generis, Bupropiom Ratiopharm
- Romania · Axabal, Elontril
- Sweden · Bupropion Accord, Bupropion Bluefish
- Slovenia · Bupropion Accord, Wellbutrin Xr
- Slovakia · Bupropion Neuraxpharm, Elontril
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b8104c98-3431-4453-bb41-4f75fda8a4a3 GET /v1/drugs/b8104c98-3431-4453-bb41-4f75fda8a4a3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "522",
"substance": "BUPROPION HYDROBROMIDE",
"productndc": "0187-5812",
"dosage_form": "TABLET, EXTENDED RELEASE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "NDA022108",
"marketing_category": "NDA"
}See everything about bupropion hydrobromide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.